It depends on your risk and the procedure
Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis
A provider will evaluate: medical history metabolic markers weight management goals current medications lifestyle factors Based on this evaluation, providers can determine which therapies align best with your health needs
Most prescribers recommend sequential therapy or semaglutide monotherapy instead
Very sugary or highly processed foods that may worsen digestive symptoms and energy fluctuations
The same MORF-057 molecule is being evaluated in a double-blind, Phase 2b placebo-controlled RCT (EMERALD-2, NCT05611671) with 282 participants meeting similar inclusion criteria but specifically requiring inadequate response to aminosalicylates, corticosteroids, immunosuppressants, or advanced UC therapies, measuring clinical remission using mMS at 12 weeks as primary endpoint